| NCT Number | NCT05964829 |
| Lead Sponsor | Cionic, Inc. |
| Conditions | Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive |
| Enrollment | 14 participants |
| Start Date | 2023-09-04 |
| Primary Completion | 2026-06 (estimated) |
| Study Completion | 2026-07 (estimated) |
| Updated on ClinicalTrials.gov | 2025-09-24 |